The NSW Health Research and Innovation Strategy 2025-2030 sets a clear vision for the next decade, outlining priorities to improve healthcare outcomes and equity for patients by strengthening research and supporting innovation. It provides a roadmap for advancing medical breakthroughs, strengthening healthcare delivery, and enhancing the experience of delivering and receiving healthcare, while driving efficiency and sustainability to support NSW’s long-term prosperity.
We play a key role in turning this vision into action. Through targeted funding, strategic partnerships, horizon scanning and policy support, we foster collaboration between health services, academia, and industry. These efforts enable growth, scale innovation, and ensure research translates into real-world benefits for patients and communities.
Structure
We sit within the NSW Ministry of Health and are part of the Clinical Innovation and Research Division. We work closely with the Agency for Clinical Innovation and the Critical Intelligence Unit.
We are comprised of three directorates:
- Commercialisation and Strategic Partnerships
- Infrastructure and Strategic Investment
- Research Methods and Clinical Trials.
Organisational chart (PDF 95.0 KB)
Performance snapshot
We are focused on enabling and supporting a vibrant research and innovation ecosystem that improves the experience of delivering and receiving care, and provides system efficiency, sustainability, and equity in access and health outcomes. The metrics below show a snapshot of the activity undertaken by us (updated monthly).
Reporting date: 30 September 2025
Grant funding
- 43% of budgeted grant funding dispensed FYTD
- 13 medical research institutes supported
- 14 research grants awarded FYTD
Research governance and ethics
- 96% approved within 90 days
- 5 international delegations: Saudi Arabia, Beijing, Oklahoma, Utah and Ontario
Clinical trials and staff
Patient impact
- 1,478 new patients in past 3 months
- 31% from rural and regional NSW
